Label Changes for:

Lamictal (Lamotrigine) Tablets, Chewable Dispersible Tablets, Orally Disintegrating Tablets and Lamictal XR (Lamotrigine)

August 2012

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – August and November 2011, and August 2012

 

August 2012

WARNINGS AND PRECAUTIONS

Multiorgan Hypersensitivity Reactions and Organ Failure
  • Multiorgan hypersensitivity reactions, also known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), have occurred with Lamictal…
 
Hide
(web3)